Shelter Pharma Limited IPO
1. Nature of Business:
a) Manufacturer of herbal products.
b) Has presence in both Human Pharma and Veterinary sectors.
2. History & Growth:
a) Started decades ago with a few products.
b) Expanded product range through in-house R & D and knowledge of Ayurveda.
c) Good market presence and acceptance in the state of Gujarat.
3. Product Portfolio:
a) Non-critical segment presence in both Human and Veterinary Pharma.
b) Offers both Over-The-Counter (OTC) and Ethical pharma products in both sectors.
c) Respected track record for product efficacy.
d) Products are competitively priced for Shelter’s target market.
4. Company’s Background:
a) Originally named Shelter Pharmacy.
b) Became Shelter Pharma Limited on 12th October 2007 under The Companies Act, 1956.
c) Promoted by Mr. Mustaqim Nisarahmed Sabugar and Mr. Shakil Nisarahmed Sabugar.
d) Transitioned from a local presence in Himmatnagar to a wider presence in Gujarat. Underwent restructuring: redefined organizational structure, product portfolio, distribution, pricing, packaging, and processes.
e) Invested in infrastructure and increased manufacturing capacity in Himmatnagar.
5. Raw Material Sourcing:
a) Sources raw materials, specifically herbs and plants, from nearby villages.
b) Direct relationships with farmers ensuring a consistent supply.
6. Market Focus:
a) Targets the rural and semi-urban markets.
b) Aims to provide high-quality, price-competitive remedies to villages.
7. Future Plans & Strategy:
a) Building management bandwidth by inducting senior professionals.
b) Strengthening its R&D systems for future domestic and international growth.
c) Has seen steady and positive growth.
d) Aggressive future growth plans: geographical expansion, hiring quality manpower, and impactful marketing campaigns.
e) Seeks active support from associates to bolster company efforts.
Objects of the Shelter Pharma Limited IPO:
Shelter Pharma Limited IPO Details:
| Open Date: | Aug 10 2023 |
| Close Date: | Aug 14 2023 |
| Total Shares: | 3,816,000 |
| Face Value: | ₹ 10 Per Equity Share |
| Issue Type: | Fixed Price Issue IPO |
| Issue Size: | 16.03 Cr. |
| Lot Size: | 3000 Shares |
| Issue Price: | ₹ 42 Per Equity Share |
| Listing At: | BSE SME |
| Listing Date: | Aug 23 2023 |
Financials of Shelter Pharma Limited IPO:
Pariculares ( In Lakhs ) |
2021 |
2022 |
2023 |
| Revenue from Operations | 2,248 | 3,006 | 3,615 |
| Other Income | 0.52 | 0.29 | 0.24 |
| Total Revenue | 2,249 | 3,006 | 3,616 |
| Cost of Materials Consumed | 2,111 | 2,685 | 2,642 |
| Change in Inventories | 3 | -100 | -6 |
| Employee Benefits Expense | 48 | 48 | 55 |
| Other Expenses | 99 | 105 | 111 |
| EBITDA | -12 | 268 | 813 |
| Depreciation & Amortisation | 12 | 17 | 16 |
| Finance Cost | 0 | 0.72 | 1.39 |
| EBIT | -24 | 251 | 797 |
| OPM (%) | -0.54% | 8.92% | 22.48% |
| PBT | -24 | 251 | 788 |
| Tax | 0.14 | 67 | 210 |
| PAT | -24 | 184 | 578 |
| NPM (%) | -1.06% | 6.11% | 16.00% |
| No.of Shares | 115.59 | 115.59 | 115.59 |
| EPS | -0.21 | 1.58 | 5 |
Comparison With Peers:
| Name of the Company | Revenue (In Crore) | PAT (In Crore) | EPS ( in Rs) | P/E | CMP | Mcap (In Crore) |
| Shelter Pharma Limited | 36 | 6 | 5.00 | 8.4 | 42 | 49 |
| Dabur India Limited | 11,530 | 1,701 | 9.64 | 58.1 | 562 | 99,642 |
| Emami Limited | 3,406 | 627 | 14.50 | 31.2 | 492 | 21,606 |
Lead Manager of Shelter Pharma Limited IPO:
Registrar of Shelter Pharma Limited IPO:
Company Address:
Discussion on Shelter Pharma Limited IPO:
1 Comment
Leave a Reply
You must be logged in to post a comment.
Avoid. Nothing much in the company in terms of Growth and Margins…..Fy22 and Fy23 financials looks managed before IPO.